WS Data Solutions
Discounted Cash Flow Rating
Sell
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Sell
Analyst Rating
Strong Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Neutral
Standard Deviation
Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Erasca, Inc. Common Stock (ERAS)
Pharmaceutical Preparations
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
10835 ROAD TO THE CURE, SUITE 140
SAN DIEGO, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
07/16/2021
Market Cap
781,123,560
Shares Outstanding
151,090,000
Weighted SO
151,087,038
Total Employees
N/A
Upcoming Earnings
08/08/2024
Beta
1.1770
Last Div
0.0000
Range
1.51-3.45
Chg
0.0550
Avg Vol
2712327
Mkt Cap
781123560
Exch
NASDAQ
Country
US
Phone
858 465 6511
DCF Diff
2.4622
DCF
0.2478
Div Yield
0.0000
P/S
139.9863
EV Multiple
-4.4264
P/FV
1.3351
Div Yield %
0.0000
P/E
-3.8049
PEG
-0.0662
Payout
0.0000
Current Ratio
16.7921
Quick Ratio
16.7921
Cash Ratio
6.9418
DSO
143.9068
DIO
0.0000
Op Cycle
143.9068
DPO
196.3904
CCC
-52.4835
Gross Margin
0.2866
Op Margin
-27.3590
Pretax Margin
-28.3656
Net Margin
-28.3656
Eff Tax Rate
-0.0571
ROA
-0.3011
ROE
-1.3194
ROCE
-0.3048
NI/EBT
1.0000
EBT/EBIT
1.0368
EBIT/Rev
-27.3590
Debt Ratio
0.1027
D/E
0.1196
LT Debt/Cap
0.0992
Total Debt/Cap
0.1069
Int Coverage
-39.9015
CF/Debt
-2.0631
Equity Multi
1.1655
Rec Turnover
2.5364
Pay Turnover
1.8585
Inv Turnover
0.0000
FA Turnover
0.1083
Asset Turnover
0.0106
OCF/Share
-0.5112
FCF/Share
-0.5129
Cash/Share
1.8751
OCF/Sales
-19.9538
FCF/OCF
1.0034
CF Coverage
-2.0631
ST Coverage
-25.9781
CapEx Coverage
-295.3369
Div&CapEx Cov
-295.3369
P/BV
1.3351
P/B
1.3351
P/S
139.9863
P/E
-3.8049
P/FCF
-6.9919
P/OCF
-5.4089
P/CF
-5.4089
PEG
-0.0662
P/S
139.9863
EV Multiple
-4.4264
P/FV
1.3351
DPS
0.0000